🇬🇧 Pf-06823859 in United Kingdom

Pf-06823859 (pf-06823859) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Status: approved

Pf-06823859 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United Kingdom

Frequently asked questions

Is Pf-06823859 approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for Pf-06823859 in United Kingdom?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.